Skip to Content

GSI 7977 (Sovaldi 400 mg)

Generic Name: sofosbuvir

Pill with imprint GSI 7977 is Yellow, Capsule-shape and has been identified as Sovaldi 400 mg. It is supplied by Gilead Sciences, Inc..

Sovaldi is used in the treatment of hepatitis c and belongs to the drug class miscellaneous antivirals. There is no proven risk in humans during pregnancy. In combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7977

Sovaldi 400 mg GSI 7977
Sovaldi 400 mg GSI 7977
Sovaldi 400 mg GSI 7977

Sovaldi

Generic Name
sofosbuvir
Imprint
GSI 7977
Strength
400 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antivirals
Pregnancy Category
B - No proven risk in humans, X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-1501

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.